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The N-methyl-D-aspartate (NMDA) receptor, a subtype of glutamate-gated ion 
channel, has been shown to be a major target of ethanol in the central nervous 
system (CNS). Previous studies have identified positions in the third and fourth 
membrane-associated (M) domains of the NMDAR GluN1 and GluN2A 
subunits that influence ethanol sensitivity. Among the alcohol sensitive sites, a 
methionine residue is highly conserved in all GluN1 and GluN2 subunits. We 
proposed the methionine position (Met-821) in the M4 domain of the GluN2C 
subunit can regulate ethanol sensitivity and ion channel gating.  
 
14 mutations were made at the methionine position, 7 substitutions yielded 
functional receptors, which can influence ethanol sensitivity, glutamate potency 
and desensitization compared to wild type NMDAR containing GluN2C subunit. 
The other 7 mutations showed small spontaneous currents with apparent 
ethanol inhibition.  
 
The predicted structure of the NMDAR indicates that alcohol sensitive positions 
in the M3-M4 intersubunit interfaces between the two subunit types interactively 
regulate ethanol sensitivity and ion channel gating. We proposed that the Met-
821 position interact with the Gly-638 or Phe-639 position in the GluN1 M3 
domain to regulate ethanol sensitivity and ion channel gating. Dual tryptophan 
mutants G638W/M821W and F639W/M821W showed small spontaneous 
currents with apparent ethanol inhibition. To test the interaction between these 
two pairs of positions, cysteine mutations were made at Gly-638, Phe-639, and 
Met-821. Dual cysteine mutants G638C/M821C and F639C/M821C yielded 
functional receptors. G638C/M821C showed significant interaction with respect 
to ethanol inhibition, suggesting these pair of positions interactively regulate 
ethanol sensitivity and ion channel gating. 
 
 
DTT reducing experiments showed DTT-potentiated currents and increased 
deactivation time constant Tau in the dual cysteine mutant G638C/M821C. 
 
In the present studies, we showed that the Met-821 position involved in 
regulating ethanol sensitivity and ion channel gating. We also showed Gly-638 
and Met-821 positions in the M3-M4 intersubunit interfaces between GluN1 and 
GluN2C subunits interactively regulate ethanol sensitivity. The results we 
observed from GluN2C-containing NMDAR are different from the previous 
discoveries in the NMDAR containing GluN2A subunit. The difference may 
mainly lies in the sequence difference between GluN2A and GluN2C M4 
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HEPES              4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 




IC50                         50% inhibitory concentration 
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Iss                  glutamate-activated steady-state current 
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MTSET              MTS-ethyltrimethylammonium 
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Chapter 1. Introduction 
The NMDA receptor: a general introduction 
The N-methyl-D-aspartate (NMDA) receptor, belonging to the ionotropic 
glutamate receptor family, is highly expressed in the central nervous system 
(CNS)[2, 3]. The NMDARs are sensitive to the specific agonist N-methyl-D-
aspartate (NMDA)[4, 5], which distinguishes NMDARs from other L-glutamate-
activated receptors (AMPA, kainite, and delta)[6]. As one of the most important 
neurotransmitter-activated ion channels in the brain, NMDAR plays critical roles 
in multiple aspects of brain function, including generating rhythms for breathing 
and locomotion activities, controlling synaptic plasticity underlying learning and 
memory processes, and regulating higher cognitive brain functions, such as 
cognition, attention, and fear[7-10].  
 
NMDA receptor development and distribution 
NMDARs are heterotetramers[1, 11-13], and functional receptors are 
assembled from two GluN1 subunits with either two GluN2 subunits or a 
combination of GluN2 and GluN3 subunits[14-16]. The GluN1 subunit, as the 
key element of tetrameric NMDARs, is present and widespread from an early 
developmental stage[17-19]. In contrast, GluN2 subunits show distinct 




GluN2B and GluN2D subunits are expressed during the prenatal stage, but 
shortly after birth, GluN2A and GluN2C subunits quickly predominate while the 
GluN2B and GluN2D subunits decline to adult levels, resulting in a limited 
distribution[20]. GluN2B expression levels peak in the hippocampus and cortex 
during the third postnatal week and then decline to the low adult levels, while 
GluN2A expression continues to increase in the hippocampus and cortex, and 
peak throughout the brain during the third postnatal week before declining to 
adult levels[21-24]. GluN2C expression is very low in the cerebellum and 
forebrain at P7, but dramatically increases in the cerebellum at P12, where its 
expression peaks throughout granule cells during the third postnatal week and 
where it continuous to be expressed at high levels in the adult as the 
predominant subunit[23, 25]. In summary, the GluN1 and GluN2A subunits are 
ubiquitous in the adult brain; the GluN2B subunit is mainly in the forebrain; the 
GluN2C subunit predominates in the cerebellum and various select nuclei; and 
the GluN2D subunit is limited to the diencephalon and the midbrain[20, 25-28]. 
 
NMDA receptor physiology 
The NMDARs are integral membrane proteins formed by four subunits, at least 
two GluN1 subunits with either two GluN2 subunits or a combination of GluN2 
and GluN3 subunits[14-16]. Each individual subunit contains four distinct 
domains: the extracellular amino-terminal domain (ATD), which is involved in 
subunit assembly, trafficking and modulation; the ligand-binding domain (LBD), 
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which participates in agonist or competitive antagonist binding and channel 
activation; the membrane-associated domains (MD), which form the 
membrane-spanning part of the receptor, and an intracellular carboxyl-terminal 
domain (CTD), which is mainly responsible for receptor localization and 
signaling regulation. Although each GluN subunit shares highly homologous 
sequence and architecture, NMDAR kinetics, regulation, and interaction with 
multiple intracellular proteins varies depending upon subunit composition[28, 
29]. First, at resting membrane potentials, most subtypes of NMDARs undergo 
rapid channel block by extracellular Mg2+, which is only relieved with 
simultaneous depolarization and synaptic release of glutamate[30-32]. 
GluN2C–containing NMDARs are ~ 10 fold less sensitive to Mg2+ block 
compared to receptors containing GluN2A and GluN2B NMDARs[14, 33]. 
Second, NMDARs are highly permeable to both monovalent cations and Ca2+ 
ions. NMDAR activation results in an influx of Ca2+ as well as the influx of Na+ 
and efflux of K+[34-37]. Ca2+ entry has been demonstrated to be the key trigger 
for many important physiological activities including long-term potentiation (LTP) 
[7, 38, 39]and long-term depression (LTD)[40-42], where the relative magnitude 
of the rise in intracellular Ca2+ concentration and its temporal and spatial 
character determines which type of synaptic plasticity is induced[43-46]. Third, 
NMDAR activation requires coincident binding of both glutamate and the co-
agonist glycine[47, 48]. Glutamate is the endogenous agonist of GluN2 
subunits[49, 50], while glycine and D-serine act as the agonist at the GluN1 
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subunit[51, 52]. In addition to glutamate, D- and L-aspartate are also 
endogenous agonists for the GluN2 subunits[53-56]. The GluN2 subunits show 
various glutamate potencies and efficacies. The GluN2A and GluN2B subunits 
have lower potency compared to the GluN2C and GluN2D subunits[14, 57, 58], 
but higher efficacy as indicated by higher open probability (Po) during the time 
when the receptor is fully occupied by agonist (intraburst Po). Fourth, NMDAR 
desensitization is defined as a reduced response in the sustained presence of 
agonist. There are at least three different processes of NMDAR apparent 
desensitization: true desensitization, in which NMDAR responses are 
diminished in the continued presence of glutamate in a time-dependent 
manner[28, 59]; glycine-dependent apparent desensitization, in which binding 
of glutamate decreases the affinity for glycine, so that NMDAR responses 
decay in the presence of low concentrations of glycine[60, 61]; calcium 
inactivation, in which intracellular Ca2+ causes a decay in NMDAR-mediated 
current through an interaction with the GluN1 subunit cytoplasmic domain[61-
63]. All forms of apparent and real desensitization are prominent in GluN2A-
containing NMDARs, but are not observable in GluN2C-containing NMDARs[14, 
64-66]. Fifth, NMDAR deactivation contributes to the EPSC time course and is 
also dependent on subunit composition. The time constants of deactivation in 
NMDARs containing GluN2C or GluN2D subunits are much higher than those 
in GluN2A- and GluN2B- containing NMDARs. 
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The NMDA receptor pharmacology 
The complicated architecture of the NMDAR provides agonists and antagonists 
with several distinct binding sites. The glycine binding site in the GluN1 subunit 
ligand-binding domain (LBD) is activated by glycine or D-serine, and blocked 
by antagonists such as 7-chlorokynurenic acid and its analog 5,7-
dichlorokynurenic acid (5,7-DCKA)[67-69]. Glutamate, NMDA, aspartate, and 
other agonists activate the glutamate binding site in GluN2 subunits and the 
classical competitive antagonists of this site are (R)-2-amino-5-
phosphonopentanoate (AP5 or APV)and its analogs, such as AP7[47]. 
Extracellular Mg2+ blocks the NMDAR channel pore at negative membrane 
potentials. Other open channel blockers, such as MK-801 and ketamine, block 
the ion channel in a manner that is not voltage-dependent, although recovery 
from block is accelerated by the outward movement of ions at positive 
membrane potentials[70]. Zinc inhibits NMDAR via dual actions: at millimolar 
concentrations, it produces ion channel block[71], and at nanomolar 
concentrations, it binds to the GluN2A ATD[72-74] of GluN2A-containing 
NMDAR to cause a rapid decay in current[75, 76]. Polyamines such as 
spermine and spermidine can inhibit or potentiate the NDMARs activities, at 
high and low concentrations respectively. At low micromolar concentrations, 
polyamines promote channel opening and at high concentrations, they block 




The NMDA receptor and alcohol addiction 
Ethanol is one of the most widely abused drugs in the world. Chronic alcohol 
exposure can cause multiple aspects of changes in brain morphology, function 
and behavior. Studies have shown that alcohol addiction not only can cause 
brain shrinkage and loss of neurons, but is associated with aberrant learning 
and memory processes[80-83]. It acts on multiple target proteins in the central 
nervous system at high millimolar concentrations[2, 3]. Among those targets, 
the NMDARs play a crucial role for the inhibitory effect of ethanol in the 
brain[84-90]. One of the earliest studies from Lovinger et al (1989). showed that 
acute ethanol exposure can inhibit NMDA-activated current in hippocampal 
neurons[91]. Later, ethanol inhibition of NMDA receptor activity was also 
demonstrated by measuring NMDA receptor-mediated excitatory postsynaptic 
potentials/currents (EPSPs/EPSCs) in slices from many different brain regions, 
such as cortex[92, 93], amygdala[94], nucleus accumbens[95, 96], 
hippocampus[91], and dorsal striatum[97, 98]. Similar inhibitory effects of 
ethanol were also found in HEK cells and Xenopus oocytes, expressing 
recombinant NMDA receptors. Single-channel recordings provided evidence 
that ethanol decreases the open channel probability and mean open time of 
NMDA receptors in cultured cortical neurons[92]. Although all of this evidence 
indicates that ethanol rapidly inhibits NMDA receptor function in vivo and in vitro, 
the precise molecular mechanisms of ethanol inhibition on the NMDA receptors 
have been difficult to determine. By using electrophysiological techniques, 
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rapidly-inhibited NMDA-evoked currents were detected in response to acute 
ethanol exposure in a concentration-dependent manner[99, 100], which 
suggested ethanol directly interacts with NMDA receptors. The questions that 
remain concern where this small molecule binds in NMDA receptors and how it 
changes NMDA receptor channel kinetics. 
 
Based on the evidence that alcohol and NMDARs antagonists produce similar 
inhibitory effects in vivo and in vitro, studies mainly focused on finding alcohol 
molecule binding sites in the agonist site or other modulatory sites. However, 
the effect of ethanol on NMDARs of cultured mouse hippocampal neurons only 
showed decreased Emax values of the NMDARs concentration-response curve 
without affecting EC50 values, which indicates that ethanol inhibit NMDARs 
activity in a non-competitive manner[86, 99, 101-103]. Whether the co-agonist 
(glycine) site can mediate ethanol’s effects was initially controversial[86, 102-
107]. Wright et al. (1996) showed that ethanol inhibition of NMDA channels 
does not involve substantial changes in fast closed state kinetics or changes in 
open channel conductance, and thus is not attributable to block of the open 
channel[92]. Peoples et al. (1997) showed there is no effect on ethanol 
inhibition of NMDA-activated currents even in the presence of different 
concentrations of Mg2+ in the cultured cortical neurons[103]. These two 
evidence indicate that alcohol molecule binding sites are not in the channel 
pore. Taken together, there is no evidence that alcohol binding sites are in the 
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extracellular structure of the NMDARs and suggests ethanol may affect 
NMDARs activities via effects on lipids or other intracellular proteins, such as 
protein kinase C (PKC). Snell et al. (1994) demonstrated the involvement of 
PKC in ethanol-induced inhibition of NMDARs in cerebellar granule cells[108]. 
In contrast, Peoples and Stewart (2002) showed C-terminal truncation mutant 
did not abolish the effect of ethanol on the NMDARs[99]. This result against the 
possibility that the alcohol inhibition on NMDARs is mediated via intracellular 
part of the receptors. Results from mutagenesis studies with alcohol- and 
anesthetic-sensitive γ-aminobutyric acid A (GABAA) and glycine receptors 
showed that mutation at a serine residue in the second transmembrane (TM2) 
domain or an alanine residue in the third transmembrane (TM3) domain greatly 
affected the potentiation of GABAA and glycine channel function by ethanol and 
volatile anesthetics[109]. Larger amino acids in the ethanol sensitive positions 
produce inhibition, while smaller amino acids producing enhanced potentiation. 
To find the alcohol action sites in the membrane-associated domain, Peoples 
and Woodward groups started a series of scanning studies in the M domain. 
Our lab first identified Met-823, a site of alcohol action in the M4 domain of the 
GluN2A subunit, which can not only alter ethanol sensitivity of GluN2A-
containing NMDAR, but can regulate glutamate potency, apparent 
desensitization, mean open time, and peak current density[110, 111]. The 
Woodward lab found Phe-639, a site in the M3 domain of the GluN1 subunit, 
which also can alter ethanol sensitivity[112]. Above evidence confirmed the 
9 
 
hypothesis that alcohol molecule can act on the sites in the membrane-
associated domains. In the following studies, a series of ethanol sensitive 
resides are recognized in both GluN1 and GluN2A subunit, Gly-638 in the M3 
domain of the GluN1 subunit, the cognate positions Phe-636, Phe-637, Met-
823, Ala825 in GluN2A subunit[110, 111, 113-115] (Figure 1). Taken together, 
these ethanol sensitive sites are hydrophobic amino acids; are not involved in 
lining the ion channel lumen; and influence ion channel gating properties.  
 
Because alcohol molecule can act on multiple sites in NMDARs, it is likely that 
ethanol sensitive residues form a small environment to regulate ethanol 
sensitivity together. Dual mutations at Phe-637 and Met823 in GluN2A subunit 
can influence ethanol sensitivity and receptor kinetics, which suggests that 
these two positions are functionally linked because modulation of ethanol by 
dual mutants is not additive[116]. Based on the reported structure of the GluA2 
glutamate receptor M domains[1], it is possible that sites of alcohol action is 
formed by groups of 4-6 residues clustered in small regions at the M3-M4 
intersubunit interfaces between GluN1 and GluN2A subunit[114] (Figure 1). By 
using two-way ANOVA and mutant cycle analysis of log-transformed ethanol 
IC50 values, significant interactions affecting ethanol inhibition was observed 
at four pairs of positions in GluN1/GluN2A: Gly-638/Met-823, Phe-639/Leu-824, 
Met-818/Phe-636, and Leu-819/Phe-637[114]. Unlike the interaction between 
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Phe637 and Met823 in GluN2A subunit, these sites can alter ethanol action in 
a manner that all side chains of interacted residues are in close proximity[114].  
 
Although accumulated evidence showed the important role of GluN1 and 
GluN2A subunit in the action of alcohol, it is largely unknown how other GluN2 
subunits are involved in the modulation. The protein sequence of M3 and M4 
domains is highly conserved through all GluN subunits. So, it is likely that 
GluN2C subunit also contain alcohol sensitive sites in the M3 and M4 domains. 
Unlike GluN2A and GluN2B subunit, GluN2C subunit has a limited distribution 
in cerebellum[20, 25-27]. The GluN2C subunit also can be found in 
thalamus[25], olfactory bulb[25], oligodendrocytes[117], and hippocampal 
interneurons[20]. The GluN2C subunit has its unique electrophysiologic and 
pharmacologic properties that differ from those of the GluN2A and GluN2B 
subunits. For example, the GluN2C-containing NMDA receptor has a lower 
open probability, being opens for only ~1% of the time during agonist 
activation[64], a lower single-channel conductance, shorter open time, lower 
sensitivity to Mg2+ block[20, 118], and higher affinity for the agonist and 
coagonist glutamate and glycine[57, 119]. In vivo studies have shown that 
GluN2C knockout mice have significant deficits in working memory and 
acquisition of conditioned fear[120], suggesting that GluN2C plays an important 
role in controlling cerebellum function. The GluN2C-containing NMDA receptor 
also shows differences in alcohol sensitivity. GluN2C-containing NMDA 
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receptors are less sensitive to ethanol compared to GluN2A- and GluN2B-
containing NMDA receptors[121-123]. To fill the gap and better understand the 
function of GluN2C subunit, we will focus on studying the molecular mechanism 




























Chapter 2. Material and Methods 
Materials  
Ethanol (95%, prepared from grain) will be obtained from Aaper Alcohol & 
Chemical Co. (Shelbyville, KY), and all other drugs will be obtained from Sigma. 
Chemicals used to make recording solutions were the highest purity available. 
 
Molecular Biology, Cell Culture, and Transfection  
Site-directed mutagenesis in plasmids containing GluN1 or GluN2C subunit 
cDNA was performed using the QuikChange II kit (Agilent Technologies, Santa 
Clara, CA), and all mutants were verified by double-strand DNA 
sequencing. TSA201 cells, a transformed human kidney 293 cell line, were 
maintained in flasks containing serum supplemented Dulbecco’s minimum 
Eagle medium in a humidified 5% CO2 incubator. For recordings, cells were 
plated onto fibronectin-coated 35mm dishes at high-density (approximately 5 × 
105 cells per dish) and transfected with GluN1, GluN2C, and green fluorescent 
protein (GFP) using the calcium phosphate transfection kit (Invitrogen). 10mM 
magnesium chloride (MgCl2) was added to the culture medium to prevent 
excitotoxic cell death. MgCl2 was removed before use in experiments by 




Electrophysiological Recording  
Whole-cell patch-clamp recording was performed at room temperature using 
an Axon 200B amplifier (Molecular Devices, Sunnyvale, CA). Patch pipettes 
(1–3 MΩ) were pulled from borosilicate glass and filled with internal solution 
containing 140 mM CsCl, 2 mM Mg4ATP, 10 mM BAPTA, and 10 mM HEPES 
(pH 7.2). The recording solution containing 150 mm NaCl, 5 mmKCl, 0.2 
mm CaCl2, 10 mm HEPES, 10 mm glucose, and 10 mm sucrose. The ratio of 
added HEPES-free acid and sodium salt was calculated to result in a solution 
pH of 7.4 (Buffer Calculator, R. Beynon, University of Liverpool).  Solutions of 
agonists and ethanol were prepared fresh daily and applied to cells using a 
stepper motor-driven rapid solution exchange apparatus (Warner Instruments, 
Inc.) and 600-μm inner diameter square glass tubing. In concentration-
response experiments, the order of application of the various concentrations of 
ethanol was randomized for each cell to eliminate time-dependent effects. Data 
were filtered at 2 kHz (8-pole Bessel) and acquired at 5 kHz on a computer 
using a DigiData interface and pClamp software (Axon Instruments).  
Cysteine Cross-linking  
Wild type and cysteine-substituted mutant receptors were treated with the 
reducing agent 10mM DTT for 3-5min. In the presence of 300 μM glutamate, 
steady-state currents were measured. The effect of DTT was calculated by the 
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equation [((Iafter/Iinitial) − 1) × 100], where Iinitial and Iafter are the stabilized current 
before and DTT treatment.  
 
Molecular Modeling 
The model of the MD of the heteromeric GluN1/GluN2C NMDAR was 
generated using the GluA2 (PDB-3KG2) as a template[1]. We first manually 
aligned the GluN1 and GluN2C sequences with the respective sequences of 
GluA2 as described in Supplemental Fig2. [1] in Discovery Studio 2.5 (Accelrys, 
San Diego, CA). Then we mutated Gly-638, Phe-639 and M821 into cysteines.  
 
Data Analysis  
In concentration-response experiments, IC50 or EC50 and n (slope factor) were 
calculated using the equation y = Emax/1 + (IC50 or EC50/x)n, where y is the 
measured current amplitude, x is concentration, n is the slope factor, 
and Emax is the maximal current amplitude. Statistical differences among 
concentration-response curves were determined by comparing log transformed 
IC50 or EC50 values from fits to data obtained from individual cells using one-
way analysis of variance (ANOVA) followed by the Dunnett test.  
 
Time constant (τ) of deactivation were determined from fits of the current decay 
after the removal of glutamate (in the continued presence of glycine) to an 
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exponential function using Clampfit (Axon Instruments/Molecular Devices). 
Cells were adequately fitted by a single exponential function.  
 
Significant interactions respect to ethanol sensitivity, steady state current and 
deactivation among mutants were determined by two-way ANOVA and by 
mutant cycle analysis[124]. Natural logarithm (ln) transformed values of WT and 
mutant IC50 or EC50 or time constant (τ) values were used for computing 
interaction free energies by using the equation ΔΔGINT = RT[ln(WT) + 
ln(mut1,mut2) − ln(mut1) − ln(mut2)], with propagated errors reported in 
standard error (SEM). ΔΔGINT ± error were analyzed using one-sample t test 
for statistical significance from zero energy, with degrees of freedom (df) = 
NWT + NMUT1+ NMUT2 + NMUT1,MUT2 − 4, where NX = number of cells used for each 







Chapter 3. A Methionine (Met-821) Position in the M4 Domain of GluN2C 
Subunit Can Alter Ethanol Sensitivity. 
Introduction 
Alcohol, one of the oldest and most widely abused drugs in the world, produces 
its effects primarily via actions on ion channels in the nervous system. The N-
methyl-D-aspartate (NMDA) receptor, a subtype of ionotropic glutamate 
receptor family, has been demonstrated to be a major target in mediating the 
inhibitory effects of alcohols in the mammalian brain. Chronic ethanol exposure 
can result in up-regulation of NMDA receptor function and enhanced glutamate-
mediated excitotoxicity[125-128]. The Lovinger and colleagues first showed 
that acute ethanol exposure can inhibit NMDA-activated currents in 
hippocampal neurons. In the following studies, ethanol inhibition on NMDARs 
activities also has been demonstrated by measuring NMDARs-mediated 
excitatory postsynaptic potentials/currents (EPSPs/EPSCs) in various slices 
from many different brain regions, such as cortex[92, 93], amygdala[94], 
nucleus accumbens[95, 96], hippocampus[91], and dorsal striatum[97, 98]. 
Similar inhibitory effects of ethanol were also observed in cell lines, like HEK293 
cells, expressing recombinant NMDARs. In single-channel studies, mean open 




The NMDAR is heterotetramer, composed of two GluN1 subunits with either 
two GluN2 subunits or a combination of GluN2 and GluN3 subunits[14-16]. The 
GluN2 subunit contains four subtypes (A-D) that arise from separate genes, 
whereas the GluN1 subunit has eight isoforms that are generated by alternative 
splicing of a single gene[129]. The subunit compositions affects the 
physiological and pharmacological properties of the NMDARs[8]. All 32 
combinations of GluN1/GluN2 subunits have been examined in the presence 
of 100mM ethanol. Generally, receptors containing GluN2A and GluN2B 
subunits are more sensitive to ethanol inhibition than receptors containing 
GluN2C and GluN2D subunits[47], suggesting subunit composition can 
influence ethanol sensitivity.  
 
Because ethanol and NMDARs antagonists produce similar inhibitory effects 
on receptor activities in vivo and in vitro, an initial question was whether ethanol 
was a NMDAR antagonist binding in the agonist binding site. However, a 
number of studies showed the effect of ethanol only decreased Emax values of 
the concentration-response curve without affecting EC50 values which indicates 
that ethanol inhibit NMDARs activity in a non-competitive manner[86, 99, 101-
103]. Peoples et al. (1996) showed ethanol inhibition on NMDARs did not 
involve substantial changes in fast closed state kinetics, changes in open 
channel conductance, or block of the open channel[92] and there was no effect 
on ethanol inhibition of NMDA-activated currents even in the presence of 
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different concentrations of Mg2+ in cultured cortical neurons[103], which 
indicates that alcohol molecule binding sites are not in the channel pore. Taken 
together, there is no evidence that alcohol binding sites are in the extracellular 
structure of the NMDARs and suggests ethanol may affect NMDARs activities 
via effects on lipids or other intracellular proteins, such as protein kinase C 
(PKC). Snell et al. (1994) demonstrated the involvement of PKC in ethanol-
induced inhibition of NMDARs in cerebellar granule cells[108]. In contrast, 
Peoples and Stewart (2002) showed C-terminal truncation mutant did not 
abolish the effect of ethanol on the NMDARs[99]. This result argues against the 
possibility that the alcohol inhibition on NMDARs is mediated via intracellular 
part of the receptors.  
 
Results from mutagenesis studies with alcohol- and anesthetic-sensitive γ-
aminobutyric acid A (GABAA) and glycine receptors showed that mutation at a 
serine residue in the second transmembrane (TM2) domain or an alanine 
residue in the third transmembrane (TM3) domain greatly affected the 
potentiation of GABAA and glycine channel function by ethanol and volatile 
anesthetics[109]. Larger amino acids in the ethanol sensitive positions produce 
inhibition, while smaller amino acids producing enhanced potentiation. 
Although the sequence and structural homology between GABAA and glycine 
and glutamate receptors are extremely low, it is likely that ethanol sensitive 
sites exist in the M domains of the NMDARs.  
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The membrane-associated domains (MD) of the NMDARs are composed of 
four segments, including M1, M3, M4 spanning the membrane[130-133] and 
M2 forming a reentrant loop[134]. Using the substituted cysteine accessibility 
method (SCAM)[135], cysteine substitution mutants were generated to identify 
channel-lining residues of the GluN1 subunit[136]. Within the M1 segment, all 
nine consecutive positions (W545-H553) were not accessible to the cysteine-
specific methanethiosulfonate (MTS) reagents in the presence of glutamate, in 
contrast the preM1 segment, defined as the segment further N-terminal to the 
M1 segment, were accessible to both MTS-ethylammonium (MTSEA) and the 
larger MTS-ethyltrimethylammonium (MTSET). These reagents can covalently 
link their positively charged -S-CH2-CH2-NH3+ or -S-CH2-CH2-N(CH3)3+ groups 
to the sulfhydryl groups of cysteines exposed to the water-accessible surface 
of the channel[134]. The overall pattern of accessibility for MTSEA and MTSET 
suggests that positions in preM1, but not in M1 itself, are exposed at the water-
accessible surface of the extracellular vestibule[136]. The SCAM results also 
shows that the regions C-terminal to M3 and N-terminal to M4 are also the 
primary determinants of the extracellular vestibule[136]. The residues in the M3 
and M4 domains are mainly involved in channel-lining.  
 
The Woodward group first examined whether positions in the M domains alter 
ethanol sensitivity. Alanine substitutions at several residues within the preM1, 
M1, and M2 domains did not produce significant changes in ethanol sensitivity. 
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In contrast, alanine mutation at GluN1 (Phe-639)/GluN2A yielded significantly 
less sensitive to ethanol than wild type[137]. Tryptophan substitution at this 
position produces slightly more sensitivity to ethanol inhibition than wild type. 
These results may suggest that the physical or chemical properties of the amino 
acid substitution at this position may be an important determinant of ethanol 
sensitivity[137]. The Phe-639 residue is highly conserved through all GluN1 and 
GluN2 subunits, suggesting a key role for this residue. Coexpressing either 
GluN1 (F639A)/GluN2B or GluN1 (F639A)/GluN2C also produce significantly 
less sensitivity, which is consistent with the results observed from mutant 
combination GluN1 (F639A)/GluN2A[137]. Although the F639A mutation 
significantly reduced ethanol sensitivity of all mutant combinations NDMARs, it 
did not fully eliminate ethanol inhibition, indicating there may be other ethanol 
sensitive sites or the cognate sites in the GluN2 subunits also play a critical role 
in altering ethanol sensitivity.  
 
Based on the assumption that additional site or sites of alcohol action in one of 
the M domains exists, we used tryptophan scanning mutagenesis and found a 
highly conserved methionine residue in the M4 domain of GluN2A subunit can 
influence NMDARs alcohol sensitivity in a manner that is related both to 
desensitization of the ion channel and the physical and chemical properties of 
the substituent amino acid[111]. GluN2A(M823C), GluN2A(M823S), and 
GluN2A(M823W) produced the lowest sensitivity to ethanol, whereas 
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GluN2A(M823F), GluN2A(M823L), and GluN2A(M823Y) resulted in the highest 
sensitivity to ethanol[111]. In the studies of alcohol action of GABAA and glycine 
receptors, it has been shown that the physical and chemical properties of 
substituent amino acid play a determinant role of ethanol sensitivity. Linear 
regression analysis of alcohol sensitivity versus hydropathy, hydrophilicity, 
hydrogen bonding, molecular volume, and polarity of the substituent was 
performed and significant linear relationships were observed between ethanol 
IC50 and both hydrophilicity and molecular volume[111].  
 
It should be noted that either GluN1 (Phe-639) or GluN2A (Met-823) are not 
able to completely eliminate the inhibitory effects of alcohol, which indicates 
alcohol molecule acts on multiple sites of the NMDARs. In the following studies 
of scanning ethanol sensitive sites, a series positions of alcohol action are 
identified in both GluN1 and GluN2A subunit, Gly-638 in the M3 domain of the 
GluN1 subunit, the cognate positions Phe-636, Phe-637, Met-823, Ala825 in 
GluN2A subunit[110, 111, 113-115]. Taken together, these ethanol sensitive 
sites are hydrophobic amino acid; are not involved in lining the ion channel 
lumen; influence ion channel gating properties. 
 
In previous studies of the role of GluN1 (Phe-639) in alcohol sensitivity 
modulation, similar significant reduced ethanol sensitivity were observed 
among the different GluN2 subunit containing NMDARs[137]. Although 
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GluN2C-containing NMDAR is much less sensitivity to ethanol compared to 
GluN2A- and GluN2B-containing NDMARs, the mutant combination GluN1 
(Phe-639)/GluN2C is still markedly less than its wild type[137]. The methionine 
residue is highly conserved among all GluN2 subunits and has been shown to 
play a critical role in alcohol action modulation in GluN2A-containing 
NMDAR[111]. So, it is likely this methionine residue can influence ethanol 
sensitivity in the GluN2C-containing NMDAR. Figure 2 shows the model of the 
GluN2C subunit with the membrane-associated domains (M1-M4), and the 
presumed location of Met-821 residue in the M4 domain of GluN2C subunit.  
 
Results 
Ethanol Inhibition by Various GluN2 Subunits at the Methionine Residue 
in M4. 
According to the previous studies in this laboratory, a methionine residue in M4 
domain of the GluN2A subunit not only regulates ethanol sensitivity, but 
influences ion channel gating[110, 111]. To determine whether the effects of 
the methionine residue on ethanol sensitivity are consistent through the GluN2 
subunits, GluN2A (M823W), GluN2B (M824W), and GluN2C (M821W) were 
coexpressed with GluN1 subunit. Surprisingly, ethanol sensitivity of GluN2 
subunits with tryptophan substitution at the methionine residue exhibited 
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differently that determined for their respective wild type counterparts (Figure 3). 
As reported previously, GluN2A (M823W) showed significantly decreased 
ethanol sensitivity[111]; in contrast, GluN2C (M821W) showed significantly 
increased ethanol sensitivity. There was no significant difference between wild 
type GluN2B and GluN2B (M824W). The slope factors of the ethanol 
concentration-response curves did not differ significantly among the subunits. 
 
Mutations at Met-821 Can Alter Ethanol Sensitivity and Glutamate 
Activation. 
Since the GluN2C (Met-821) position involved in altering ethanol sensitivity, we 
made 14 mutations at the methionine position to determine how this position 
regulates ethanol sensitivity. There were 7 mutations yielded functional 
receptors and were tested inhibited by ethanol in a concentration-dependent 
manner. Ethanol IC50 values among the mutants varied ranging from 138 to 215 
mM (ANOVA, p < 0.0001).The slope factors of the ethanol concentration-
response curves did not differ significantly among the various mutants. 
Expression of the mutant subunits GluN2C (M821L), GluN2C (M821S), 
GluN2C (M821W) with GluN1 subunits resulted in the highest sensitivity to 
ethanol. Tryptophan, the largest and most hydrophobic amino acid, 
unsurprisingly produced the greatest effect of alcohol action on the receptor 
with ethanol IC50 value of 138 mM. Alanine, the smallest hydrophobic amino 
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acid that is unlikely to destabilize α-helical regions, is predicted to eliminate or 
diminish hydrophobic interactions present between larger side chains. However, 
GluN2C (M821A) did not alter ethanol sensitivity(Figure 4).  
 
Surprisingly, a number of amino acid substitutions at this site yielded 
nonfunctional receptors. M821D, M821F, M821G, M821N, M821R, M821V, 
M821Y exhibited abnormal ion channel function. The abnormal functional 
mutants exhibited small spontaneous currents with apparent ethanol inhibition. 
This is the first time in this laboratory we observed ion channel behavior like 
these mutants(Figure 4).  
 
Ethanol Sensitivity is Independent of the Physical and Chemical 
Properties of the Substituent at GluN2C (Met-821). 
In the previous study showing that GluN2A (M823W) can alter ethanol 
sensitivity of the GluN2A-containing NMDAR, a linear relation was observed 
between ethanol IC50 and hydrophilicity (R2 = 0.522; p < 0.05) and molecular 
volume (R2 = 0.683; p < 0.005) of the substituent[111]. If the observed changes 
in ethanol sensitivity among the GluN2C (Met-821) mutant subunits were due 
to a direct interaction of ethanol with this site, a significant linear relation of 
ethanol IC50 with the physical and chemical properties of the amino acid 
substituent at this site is expected. To evaluate the relative contribution of the 
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physicochemical parameters of the amino acid at this site to alcohol sensitivity, 
linear regression analysis of ethanol IC50 values versus hydropathy, 
hydrophilicity, molecular volume and polarity of the substituent were 
performed[111]. There was no significant linear relation observed between 
ethanol IC50 values and hydropathy (R2 = 0.007; p > 0.05), hydrophilicity (R2 = 
0.09; p > 0.05), molecular volume (R2 = 0.205; p > 0.05), or polarity (R2 = 
0.047; p > 0.05) (Figure 5). Although we did not detect any correlation, we 
observed a positive trend between ethanol IC50 values and hydrophilicity, and 
a negative trend between ethanol IC50 values and molecular volume, which 
may due to missing plots. There were seven mutations that showed abnormal 
glutamate activation.    
 
Triheteromeric GluN1/GluN2A/GluN2C M821G NMDAR Can Restore Ion 
Channel Gating Function. 
Mutations at the methionine residue yielded abnormal functional mutants, 
including M821D, M821F, M821G, M821N, M821R, M821V, M821Y. It is likely 
that the Po of these mutants may be too low for detecting glutamate-activated 
currents. So, we coexpressed GluN1, GluN2A, GluN2C subunits to form 
triheteromeric NMDARs, in which GluN2A subunit increases the Po of the 
receptors and stabilize the conformation to induce channel gating. Because 
GluN2A subunit is supposed to contain a high affinity Zn2+ binding site in the 
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ATD[138], whereas GluN2C subunit does not, diheteromeric GluN1/GluN2A 
NMDAR is highly sensitivity to Zn2+ modulation. 200nm Zn2+ is sufficient to 
cause almost 100% inhibition on the diheteromeric GluN1/GluN2A 
NMDAR[139]. Triheteromeric GluN1/GluN2A/GluN2C NMDAR restores half 
sensitivity to nanomolar Zn2+ modulation[139]. We observed similar effects that 
200 Zn2+ inhibited almost all diheteromeric GluN1/GluN2A NMDAR and 
diheteromeric GluN1/GluN2C, GluN1/GluN2C M821G NMDARs was not 
sensitive to nanomolar concentration Zn2+ inhibition and triheteromeric 
GluN1/GluN2A/GluN2C NMDAR restores half sensitivity to Zn2+. We then 
coexpressed triheteromeric GluN1/GluN2A/GluN2C M821G NMDAR, which 
yielded functional receptor and Zn2+ produced half inhibition on the 
triheteromeric receptor(Figure 6). The functional triheteromeric 
GluN1/GluN2A/GluN2C M821G NMDAR seems to restore agonist sensitivity 
because a GluN2A subunit may induce receptor gating by inducing activation 
of the GluN2C (M821G) subunit. 
 
Discussion 
The results of the present study demonstrate that mutations at the highly 
conserved methionine (Met-821) in the M4 domain of the GluN2C subunit can 
influence ethanol sensitivity of the GluN2C-containing NMDAR. As expected, 
the largest amino acid tryptophan produces largest change in the ethanol IC50 
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values compared to wild type. In contrast, an alanine mutation at this position 
did not yield any significant change of ethanol sensitivity. These results are not 
in agreement with the hypothesis that alanine would alter ethanol sensitivity by 
eliminating or diminishing hydrophobic interactions present between larger side 
chains. We also observed a number of amino acid substitutions at this site 
yielding abnormal functional receptors, which did not exhibit glutamate-
activated currents, but showed apparent ethanol inhibition in the presence of 
both glutamate and ethanol. Although it has been reported in the GluN2A (Met-
823) paper that several nonfunctional receptors were yielded when methionine 
was replaced by other amino acid[111], this is the first observation that the 
channel did not open properly, but still responded to the inhibitory effects of 
ethanol.  
 
Although diheteromeric GluN1/GluN2C (M821G) has abnormal function, 
triheteromeric GluN1/GluN2A/GluN2C (M821G) restored ion channel gating 
function. GluN2C-containing NMDAR has an extremely low open probability 
(Po~1%)[64], and a lower single-channel conductance of approximately 
35pS[20, 118]. In contrast, NMDAR containing GluN2A subunit has a 50-fold 
greater open probability (Po~50%) compared to GluN2C-containing 
NMDAR[140]. The subunit-specific gating of NMDARs is controlled by the 
region formed by the ATD of the GluN2 subunit[140]. Moreover, single-channel 
analysis from mutations at GluN2A (M823) showed the substitutions at this 
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position can alter ion channel gating[110]. Taken together, it is likely that 
abnormal functional mutants have an extremely low open probability, which 
resulted in negligible glutamate-activated currents, but the coincidently opened 
channel still responded to ethanol and exhibited ethanol inhibition of these 
currents. Triheteromeric GluN1/GluN2A/GluN2C (M821G) NMDAR containing 
an ATD from the GluN2A subunit increases open probability and induces the 
channel to gate properly.  
 
The functional mutations at Met-821 residue all produced glutamate-activated 
currents and ethanol-inhibited currents. The ethanol IC50 values among the 
mutants are all different: M821L, M821S, and M821W mutants produced the 
highest sensitivity to ethanol. Taken together with our previous studies in 
GluN2A[111], this suggests that some physical or chemical properties of the 
amino acid substitution at this position may be an important determinant of 
ethanol sensitivity[109]. We thus expected a significant linear relation of ethanol 
IC50 with the physical and chemical properties of the amino acid substituent at 
this site. However, the results showed no correlation between ethanol IC50 
values and any physicochemical parameters of the amino acid, suggesting 
ethanol sensitivity is not simply represented by physical and chemical 




It has been reported that alcohols and anesthetics bind to the sites between M2 
and M3 domains of GABAA and glycine receptors and regulate channel function 
in a molecular volume dependent manner[109, 141-143]. Our lab reported a 
similar volume occupation effect at GluN2A (Met-823): a significant linear 
relation of ethanol sensitivity with molecular volume was observed when the 
value for the tryptophan mutant was excluded from the analysis[111]. All the 
evidence above suggested that the action of alcohol molecule involves filling a 
critical volume in a cavity formed in part by this site and the presence of a 
tryptophan, with the largest side chain, severely disrupts normal channel 
function and ethanol inhibition[111]. However, in the case of the GluN2C 
subunit, the increased ethanol sensitivity of the tryptophan mutant at Met-821 
is in agreement with the volume occupation theory, and suggests that 
tryptophan does not disrupt channel function or the ability to interact with the 
alcohol molecule. 
 
In the study of GluN1(Phe639), it has been shown that F639W can alter ethanol 
sensitivity in a non GluN2 subunit dependent way such that any GluN2 subunit 
coexpressed with GluN1(F639W) showed reduced inhibitory effects of 100 mM 
ethanol compared to their respective wild type counterparts[137]. Although like 
the phenylalanine residue, the methionine residue in the M4 domain is highly 
conserved through all GluN2 subunits, comparison between wild type and 
tryptophan mutants among GluN2 subunits showed that the methionine 
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position regulates ethanol sensitivity in a GluN2 subunit dependent manner. 
GluN2A (M823W) showed significantly decreased ethanol sensitivity, whereas 
GluN2C (M821W) significantly increased ethanol sensitivity, and there was no 
significant difference in ethanol sensitivity between the wild type GluN2B and 
GluN2B (M824W). These results are consistent with our previous evidence that 
alcohol action involves multiple adjacent residues that form a small environment 
to regulate ethanol sensitivity together[114]. In addition to the Met-823 residue, 
our lab found a phenylalanine residue in the M3 domain of the GluN2A subunit, 
the cognate site of GluN1 (Phe-639).  Dual mutations at Phe-637 and Met823 
in GluN2A subunit can influence ethanol sensitivity and receptor kinetics, which 
suggests that these two positions are functionally linked because modulation of 
ethanol by dual mutants is not additive[116]. Functional interactions not only 
occur between the residues within M3 and M4 domains in the same subunit, 
but direct interactions can also be observed between residues in the M3 and 
M4 domains from different subunits. By using two-way ANOVA and mutant 
cycle analysis of log-transformed ethanol IC50 values, significant interactions 
affecting ethanol inhibition were observed between multiple intersubunit M3/M4 
domain pairs, including GluN1 (G638W)/GluN2A(M823W) [114]. Unlike the 
interaction between Phe637 and Met823 in the GluN2A subunit, the side chains 




Considering the important role of GluN2C (Met-821) in regulation of alcohol 
action, we studied its role in altering ion channel gating and its possible 





















Chapter 4. A Methionine In the M4 Domain of the GluN2C Subunit Can 
Alter Ion Channel Gating. 
Introduction 
Ionotropic glutamate receptors, including NMDA, AMPA, kainate, and delta 
receptors, are integral membrane proteins composed of four large subunits, 
which form a central ion channel pore. High similarity in sequence alignment 
among the ionotropic glutamate receptors family suggests that these receptors  
share a similar architecture. A glutamate receptor subunit contains four discrete 
semiautonomous domains: the amino-terminal domain (ATD), the ligand-
binding domain (LBD), the membrane-associated domain (MD), and the 
carboxyl-terminal domain (CTD)[1]. 
 
The ATDs share sequence homology and structurally similarities with the 
LBD[1]. To study the function of the ATDs, numerous mutant subunits have 
been constructed including those lacking the entire ATD[73, 144-151]. 
Truncations in the ATD do not affect receptor assembly, and there are 
functional similarities between the truncated mutants and wild type receptor, 
suggesting a nonessential, regulatory role of the ATD for core function[10]. 
Evidence that the ATD can influence open probability, deactivation, 
desensitization, and subunit-specific assembly is consistent with regulatory 
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roles of the ATD[72, 140, 152-155]. Moreover, the ATD also harbors binding 
sites for divalent cations, such as Zn2+[72], and subunit-selective negative 
allosteric modulators, such as ifenprodil[156]. The ATD has a clamshell-like 
structure, composed of two lobes-R1 and R2, tethered together by loops[150]. 
Binding of Zn2+ to GluN2A or ifenprodil to GluN2B subunits seems to stabilize 
a closed-cleft conformation of the ATD[150]. 
 
The LBD also has a clamshell-like architecture containing two lobes-S1 and S2, 
which are structurally similar to the ATD[157]. The S1 was identified by the 
region of extracellular N-terminal domain preceding the PreM1 domain, and S2 
is the loop between the M3 and M4 domains[157-160]. Between the S1 and S2 
segment, there is an agonist binding pocket[1, 161, 162]. The activation of 
glutamate receptors involves simultaneous binding of agonists, such as 
glutamate, NMDA, and the coagonists, such as glycine or D-serine, to the 
GluN2 and GluN1 subunits, which leads to conformational change to enclose 
the agonists in the binding sites[157, 161, 163]. This conformational event 
triggers the subsequent transition of the channel pore into an open state[10, 
164, 165]. In the open state, both the LBD and MD are in an unstabilized state, 
and stability can be restored by LBD reopening to allow agonist dissociation[10, 
164, 165]. In the agonist-bound state, the LBD dimer interface will go through 
a rearrangement, allowing the receptor to enter a desensitized state[166-168]. 
Other forms of apparent NMDAR desensitization are related to glycine[60, 61] 
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or intracellular Ca2+[61-63], and real or apparent ion channel desensitization 
can influence the amplitude, duration, and following frequency of NMDA-
mediated synaptic events[61]. 
 
The MD is connected to the LBD by three short peptide linkers[1]. The MD of 
the NMDARs is composed of four segments, M1, M3, and M4 which span the 
membrane[130-133] and M2 which forms a reentrant loop[134]. The 
transmembrane helices M2 and M3 from each of the four subunits contribute to 
formation of the channel pore. In the previous chapter, we have discussed 
SCAM results of the MD. According to the cysteine substitution channel-lining 
experiments, the overall pattern of accessibility for MTSEA and MTSET 
suggests that preM1, but not M1 itself, are exposed at the water-accessible 
surface of the extracellular vestibule and the regions C-terminal to M3 and N-
terminal to M4 are also the primary determinants of the extracellular 
vestibule[136].  
 
Unlike other domains, the CTD is the most diverse one, varying in sequence 
and length among the glutamate receptor family[10]. The CTD mainly involves 
in regulatory effects on receptor localization and function. The CTD of GluN1 
subunit contains a number of regulatory protein binding sites, including sites for 
Ca2+/calmodulin[169], scaffold proteins as well as phosphorylation sites for 




Although the functional role of each structural element in the entire subunit has 
been well characterized, the nature of the conformational changes and 
molecular determinants underlying NMDARs are still largely unknown. 
Numerous evidence shows that the LBD is structurally and functionally linked 
to the MD. The dynamics between these two structural elements can affect 
each other reciprocally. From the early work on GluN1 (F639W), it is known that 
this position not only alters alcohol action of the NMDARs, but affects channel 
properties, such as glycine potency. The increased affinity for glycine but not 
glutamate[137] is consistent with the evidence that GluN1 subunit contains 
glycine binding site, whereas GluN2 subunits provide glutamate binding sites[1]. 
Our previous work on GluN2A (M823W) showed that mutation at the 
methionine position only altered the steady state glutamate EC50 values, 
instead of glycine EC50 values[110]. Taken together, sites in the MD also can 
influence ion channel gating and may be involved in transducing agonist binding 
into ion channel gating[110, 172, 173]. Mutations at MD not only affect agonist 
potencies, but receptor kinetics, such as mean open time (MOT), deactivation, 
and desensitization. GluN2A (M823W) mutant receptors have dramatically 
altered apparent desensitization, and increased mean open time[110]. GluN2A 
(F637W) and (F636W) mutant receptors also show alterations in glutamate 





Effects of mutations at GluN2C (Met-821) on glutamate potency and 
desensitization. 
According to previous work on the cognate site GluN2A (Met-823), mutations 
at this position not only affected alcohol action of the receptors, but 
physiological characteristics, such as glutamate potency and desensitization. 
To test whether the GluN2C (Met-821) residue can also affect glutamate 
sensitivity and desensitization, we performed concentration-response 
experiments for glutamate in the functional mutants using a rapid solution 
exchange apparatus in lifted cells. For the functional mutants, significant 
differences were obtained in the EC50 values for glutamate-activated 
peak (P<0.001; ANOVA) and steady-state (P<0.001; ANOVA) current and for 
the steady-state to peak current ratio (Iss:Ip; P<0.0001; ANOVA). The EC50 
values for glutamate-activated peak current were altered among the majority of 
functional mutants, but the EC50 values for steady-state current were changed 
only in the M821I, M821L, and M821S mutants. Surprisingly, the tryptophan 
mutant only had a difference in the peak EC50 value, but not steady-state EC50 
value. The slope factors of the glutamate concentration-response curves for 
both peak and steady-state did not differ significantly from the wild type values 
in any of the mutants. Apparent desensitization was affected by most of the 
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mutations, even when steady-state EC50 values were unchanged. It also should 
be noted that there was no observable desensitization in the wild type GluN2C 
subunit(Figure 7).  
 
In the previous studies, we reported that a linear correlation was obtained 
between either peak EC50 values versus steady-state EC50 values or 
peak/steady-state EC50 values versus the steady-state to peak current ratio 
(Iss:Ip)[110, 113]. However, we did not obtain any kind of correlation (Figure 8). 
 
Effects of GluN2C (Met-821) Mutants on Deactivation. 
One of the prominent features of glutamate receptors in gating kinetics are time 
course of deactivation, which mediate a majority of excitatory synaptic 
transmission. One unique physiological property of GluN2-containing NMDAR 
is unusually prolonged deactivation time course following the removal of 
glutamate. To measure the maximal response, the co-agonist glycine was 
present in all solutions (50μM), which saturated all the glycine binding sites, 
and current responses were evoked with 300μM glutamate. GluN2C-containing 
NMDAR deactivated slowly with a single exponential time course with time 
constants ranging from 1098 to 2183 ms (Figure 9). We subsequently analyzed 
time constants of deactivation for other mutants at the Met-821 position. There 
was a significant difference among the mutants compared to wild type 
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(P<0.0001; ANOVA). M821L, M821T, M821W mutants have the most 
significant changes for the deactivation. It should be noted that the steady-state 
EC50 value of tryptophan mutant does not have difference compared to wild 
type receptor, while deactivation time course of this mutant becomes faster than 
wild type.  
 
Discussion 
The results of the present study demonstrate that alcohol sensitive position 
Met-821 in the M4 domain of the GluN2C subunit is involved in regulating ion 
channel gating and receptor kinetics. The tryptophan mutant can alter 
glutamate-activated peak current, but not steady-state current EC50 values. The 
steady-state to peak current ratio (Iss:Ip) also changed because of the attribution 
of the significantly increased peak EC50 values. We performed linear regression 
analysis between either peak EC50 values versus steady-state EC50 values or 
peak/steady-state EC50 values versus the steady-state to peak current ratio, 
and found that there was no correlation between any of these pharmacological 
parameters. In the studies of cognate site GluN2A (Met-823), we reported that 
steady-state EC50 values were highly correlated with steady-state to peak 
current ratio, which was interpreted as agonist trapping on desensitized 
receptors causing increased affinity[110]. The present studies of GluN2C (Met-
823) showed that a majority of mutations at these position significantly increase 
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the peak EC50 values without affecting the steady-state EC50 values. In contrast, 
mutations at GluN2A (Met-823) only affected steady-state EC50 values instead 
of peak EC50 values[110]. Taken together, the underlying mechanism at Met-
821 appears to differ from the trapping mechanism observed at GluN2A (Met-
823).  
 
GluN2C-containing NMDAR deactivated slowly with a single exponential time 
course with time constants ranging from 1098 to 2183 ms, which is 
approximately 40-fold longer compared to receptors containing GluN2A[66, 
174] . The deactivation tau of the M821W mutant 1291±160 ms, is significantly 
different from wild-type and other mutants at this position. Several lines of 
investigation have identified there are several factors that can regulate 
deactivation time constant of NMDARs, such as the rates of ligand association 
and dissociation, which are the primary determinants of the deactivation time 
course[10]. We have showed that dual tryptophan mutant combinations GluN1 
(L819W)/GluN2A (F637W) can significantly interact with each other to alter 
deactivation[114]. The observations in this study provide additional evidence 
that mutations at MD also can affect time course of deactivation. 
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Chapter 5. A Methionine (Met-821) Position in the M4 Domain of GluN2C 
Subunit Can Interact with Positions in the M3 Domains of GluN1 Subunit. 
Introduction 
Ethanol is one of the common drugs of abuse and acts at high concentrations 
(millimolar) on multiple targets in the central nervous system to regulate 
neuronal activities[2, 3]. Among those are mainly channels gated by the 
neurotransmitter glutamate, the major excitatory neurotransmitter in the 
mammalian brain. The N-methyl-D-aspartate (NMDA) receptors, subtypes 
belonging to the glutamate receptor family, play the most crucial role for the 
inhibitory effect of ethanol[84, 85]. The first evidence that ethanol inhibited 
NMDAR evoked currents in hippocampal neurons was shown by Lovinger et al. 
(1989)[91]. Subsequent studies using radiolabeled neurotransmitter release, 
calcium uptake, and ratiometric calcium indicators confirmed that NMDARs are 
inhibited by alcohol across a wide range of brain regions[175]. Although there 
is numerous studies leading to the conclusion that ethanol inhibits NMDAR 
function, the mechanism of alcohol action remains unclear. The inhibitory effect 
of alcohol action on NMDA-evoked currents is in a voltage-independent manner 
and is not involved in altering single channel conductance, suggesting that 
alcohol molecule does not act as an ion channel pore blocker[92, 176]. There 
is also evidence showing that ethanol inhibition is not relate to competitive 
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inhibition at the glycine and glutamate binding sites[86, 101, 103, 107, 123], or 
allosteric modulation[103, 121]. In addition, although the phosphorylation sites 
in the CTD, in some instances, modulate ethanol sensitivity of the NMDARs[95, 
175, 177], receptors lacking the CTD still show sensitivity to ethanol[99].  
 
Ronald et al. first found a phenylalanine residue (Phe-639) in the M3 domain of 
the GluN1 subunit influences alcohol sensitivity[137]. The previous studies from 
our laboratory also identified a number of alcohol sensitive sites, including two 
phenylalanine residues (Phe-636) and (Phe-637) in the M3 domain of the 
GluN2A subunit[113, 115], a methionine residue (Met-823) and an alanine 
residue (Ala-825) in the M4 domain of the GluN2A subunit[111, 114]. Although 
these residues can alter ethanol sensitivity of NMDARs, mutations at these 
sites did not abolish ethanol inhibition. Studies in GABAA and glycine receptors 
showed residues in transmembrane domains two and three forming sites of 
alcohol and anesthetic action[109, 178]. Based on these results, we tested the 
role of dual tryptophan mutants GluN2A (F637W M23W) in influencing ethanol 
sensitivity and receptor function. We observed that dual mutations at Phe-637 
and Met823 in GluN2A subunit can interactively influence ethanol sensitivity 
and receptor kinetics, which suggests that these two positions are functionally 
linked because modulation of ethanol by dual mutants is not additive[116]. After 
this study was performed, the high-resolution structure of an ionotropic 
glutamate receptor was reported [1]. Our group subsequently showed that sites 
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of alcohol action are formed by groups of 4-6 residues clustered in small regions 
at the M3-M4 intersubunit interfaces between GluN1 and GluN2A subunit[114]. 
By using two-way ANOVA and mutant cycle analysis of log-transformed ethanol 
IC50 values, significant interactions affecting ethanol inhibition were observed 
at four pairs of positions in GluN1/GluN2A: Gly-638/Met-823, Phe-639/Leu-824, 
Met-818/Phe-636, and Leu-819/Phe-637[114] (Figure 1). Unlike the functional 
interaction between Phe637 and Met823 in GluN2A subunit, these side chains 
appear to physically interact with one another, which is consistent with the 
proposed model that places these pairs of positions in close proximity [114]. 
 
Unlike GluN2A-containing NMDAR, which predominates in mammalian brain 
and has been shown to be involved in multiple brain functions, GluN2C-
containing NMDAR are mainly expressed in cerebellar granule neurons[20, 25-
27], thalamus[25], olfactory bulb[25], oligodendrocytes[117], and hippocampal 
interneurons[20]. The GluN2C subunit has unique electrophysiological and 
pharmacologic properties that differ from those of the GluN2A subunit. For 
example, the GluN2C-contianing NMDA receptor has a lower open probability, 
being open for only ~1% of the time during agonist activation[64], a lower single-
channel conductance, shorter open time[20, 118], higher affinity for the agonist 
and coagonist glutamate and glycine[57, 119], and much less sensitivity to 
ethanol compared to GluN2A-containing NMDAR[121-123]. To understand the 
role of GluN2C subunit in regulating ethanol sensitivity and channel gating 
43 
 
function, the cognate position Met-821 in the M4 domain was substituted by 
tryptophan and showed different alcohol sensitivity, glutamate potency and 
desensitization. Dual tryptophan mutants GluN1 (G638W)/ GluN2C (M821W) 
and GluN1 (F639W)/ GluN2C (M821W) showed abnormal channel gating 
activity in the presence of glutamate, which may suggest apparent interactions 
between these two pairs of positions at the intersubunit interface in the M3 and 
M4 domains of the GluN1 and GluN2C subunits. In this study we introduced 
cysteine mutations in the GluN1 at G638, F639 and in the GluN2C at M821. 
Significant changes in ethanol sensitivity, agonist affinity, and deactivation have 
been observed and mutant cycle analysis also showed an interaction between 
the dual cysteine mutants. Based on these findings, we propose that two pairs 
of positions can interact and play a crucial role for ethanol sensitivity modulation 
and channel gating activity. 
 
Results 
Effects of Dual Tryptophan Mutants on Glutamate Activation. 
Our previous studies have identified significant interactions altering ethanol 
sensitivity between the GluN1 (G638) and GluN2A (M823) positions[114]. We 
predicted that the cognate sites in GluN2C-containing NMDAR M3-M4 
intersubunit interfaces would exhibit a similar interaction consistent with a site 
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of alcohol action. Using tryptophan substitution, we first tested whether single 
tryptophan mutants at GluN1 (G638), GluN1 (F639), GluN2C (M821) could alter 
ethanol sensitivity. Tryptophan is the largest amino acid and has consistently 
produced the greatest effect on ion channel behavior in previous studies from 
this laboratory[110, 111, 113-115]. All of the single tryptophan mutants 
exhibited increased alcohol sensitivity, in which the ethanol IC50 value was 
significantly decreased (p <0.0001; ANOVA) (Figure 10). We next coexpressed 
either GluN1 (G638W) or GluN1 (F639W) with GluN2C (M821W), which is 
predicted to be in close proximity. However, neither G638W/M821W nor 
F639W/M821W exhibited observable glutamate-activated currents.  
 
Coexpressed Cysteine Mutants in the M3 and M4 Domains of GluN1 and 
GluN2C Subunits Interact to Regulate Ethanol Inhibition. 
The GluN1 (G638W)/GluN2C (M821W) GluN1 (F639W)/GluN2C (M821W) dual 
tryptophan mutants were not sensitive to glutamate, but both mutants appeared 
to respond to ethanol, in that very small apparent spontaneous currents in these 
mutants were inhibited by 100mM ethanol. These may be due to the side chain 
of tryptophan at one position, which may interact with the side chain of the other 
one to disrupt the ion channel gating activity. To test whether the sites in the 
M3 and M4 domains intersubunit interfaces can interact, we made cysteine 
substitution at G638, F639 and M821 positions. All of the single cysteine 
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mutants did not alter ethanol sensitivity, but ethanol IC50 value in the mutant 
combination G638C/M821C differed significantly from the wild type (p < 0.0001; 
ANOVA) (Figure 11). Interestingly, we observed the opposite results in the 
mutations F639C/C744A and F639C/C744A/M821C, in which the redox site 
Cys744 is substituted by alanine, decreased ethanol sensitivity. We next used 
both two-way analysis of variance (ANOVA) on log-transformed IC50 values and 
mutant cycle analysis to calculate whether there were significant free energy 
changes. We found an interaction between the mutant combinations of 
G638C/M821C and G638C/C744A/M821C, as both types of analysis were 
statistically significant. In contrast, we did not detect any interaction in 
F639C/M821C, but in F639C/C744A/M821C (Figure 12). 
 
Coexpressed Cysteine Mutants in the M3 and M4 Domains of GluN1 and 
GluN2C Subunits Can Regulate Glutamate Potency. 
To determine whether dual cysteine mutants also influence glutamate potency, 
we compared EC50 values for glutamate activation of steady-state currents. 
Both single cysteine mutants GluN1 (F639C) and GluN2C (M821C) showed 
different glutamate EC50 values and highly significant differences were obtained 
in dual cysteine mutants F639C/C744A/M821C (p < 0.0001; ANOVA) (Figure 
13). Interestingly, although G638C/M821C exhibited significantly altered IC50 
value, it was not involved in changing steady-state glutamate potency; 
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F639C/M821C did not change ethanol sensitivity, but varied the agonist affinity. 
After removing the redox site Cys744, we observed both dual cysteine mutants 
G638C/C744A/M821C and F639C/C744A/M821C significantly altered 
glutamate EC50 values.  
 
Coexpressed Cysteine Mutants in the M3 and M4 Domains of GluN1 and 
GluN2C Subunits Can Regulate NMDA Receptor Kinetics. 
Our previous results have shown that dual tryptophan mutants GluN1 
(G638W)/GluN2A (M823W) can interact to alter NMDA receptor kinetics[114]. 
If the side chain of cysteine at G638 or F639 in the GluN1 M3 domains interact 
with the side chain of cysteine at M821 in the GluN2C M4 domains and are 
involved in regulating ion channel function, dual cysteine mutants should also 
affect relevant ion channel behaviors. We measured time of decay among the 
mutants: the cysteine mutants containing redox site Cys744 all showed 
markedly decreased time constant of deactivation compared to wild type, while 
the mutants with C744A all increased the time of decay. We observed 
extremely prolonged deactivation in the mutant GluN1 (F639CC744A)/GluN2C 
(Figure 14). Then, we analyzed interactions among the dual cysteine mutants 
respect to deactivation. In the group containing redox site C744, although time 
constants of deactivation differed among the various mutants, we did not 
observed significant interactions with respect to deactivation between 
47 
 
G638C/M821C and F639C/M821C; while in the group with C744A, significant 
interaction was obtained in the mutant combination F639C/C744A/M821C 
(Figure 15).  
 
Cross-linking Between Cysteine Substitutions in the M3 and M4 Domains 
of GluN1 and GluN2C Subunits. 
To confirm whether G638/F639 and M821 are sufficiently spatially proximal to 
interact, we examined the effects of applying the reducing reagent DTT among 
the mutants. Previous work from other laboratories has reported that a pair of 
cysteine residues, Cys744 and Cys798 in GluN1, is responsible for the 
potentiation of GluN1/GluN2A by DTT, and that redox modulation can be 
completely abolished in the mutant GluN1 (C744A, C798A)/GluN2C[179-181]. 
To eliminate the effect of endogenous redox sites, we substituted cysteine at 
C744 with alanine. However, we did not observe DTT-potentiated currents in 
either GluN1/GluN2C or GluN1(C744A)/GluN2C. We then examined the effects 
of DTT on all the single and dual cysteine mutations. As expected, significant 
potentiation was only obtained among dual cysteine mutants. There was no 
effect of DTT treatment on current amplitude in any single cysteine mutant. In 
contrast, when either the GluN1 (G638C) or GluN1 (F639C) mutants (with or 
without the C744A mutation) were expressed with GluN2C (M821C), DTT 
treatment significantly increased current amplitudes (Figure 16). We also 
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compared time constants of deactivation after DTT exposure among the 
mutants, and observed significant increases in time constants of decay in dual 
cysteine mutants containing the Cys744 residue, but not in those containing 
C744A (Figure 17).  
 
Discussion 
These experiments were aimed at determining whether residues in GluN1 M3 
and GluN2C M4 at the intersubunit interfaces interact to alter ethanol sensitivity 
and NMDA receptor ion channel behavior. We have observed that single 
tryptophan substitutions at GluN1 (G638), GluN1 (F639), or GluN2C (M821) 
can alter ethanol IC50 values, but neither GluN1 (G638W)/GluN2C (M821W) 
nor GluN1 (F639W)/GluN2C (M821W) receptors exhibit glutamate-activated 
current. However, both dual tryptophan mutants exhibit small-amplitude 
spontaneous currents that respond to ethanol. Apparent ethanol inhibition has 
been observed between these two mutants. These results are mostly in 
agreement with the results from our previous findings[114] and suggest 
apparent interaction between G638W/M821W or F639W/M821W may be too 
strong to disrupt NMDA receptor function. Based on the x-ray crystallographic 
structure of the GluA2 subunit[1] and the structural model of the NMDAR M 
domains[114], we predict these two pairs of residues are in close proximity to 




Our previous work demonstrated that the side chains of one amino acid can 
interact with one another to alter ethanol sensitivity[114]. In this study, we made 
cysteine mutations at the above positions to determine the effects of amino acid 
side chain interaction. Using both two-way ANOVA and mutant cycle analysis, 
significant interaction was observed between GluN1 (G638C)/GluN2C (M821C), 
which is consistent with our previous results[114]. Redox site modulation 
experiments also demonstrated that a disulfide-bond is spontaneously formed 
between these two positions that alters current amplitude, and that the disulfide 
bond can be reduced by DTT to enhance glutamate-activated currents. 
Although this study does not directly answer the question about which 
coexpressed tryptophan mutations at GluN1 (G638)/GluN2C (M821) interacts 
to alter ethanol sensitivity and NMDA receptor function, we have demonstrated 
that the side chain of one cysteine can interact with one another in mediating 
the action of alcohol. These results are consistent with our previous findings in 
GluN1 (G638W)/GluN2A (M823W)[114].  
 
NMDARs are regulated by an extracellular redox state and both GluN1 and 
GluN2 subunits are involved in redox modulation. Two disulfide bonds have 
been found within GluN1 subunit, including Cys744 and Cys798 in the LBD and 
SVC79ED and RGC308VG in the ATD[179, 181]; Cys87 and Cys320 are 
proposed to form a disulfide bond within the ATD of GluN2A subunit[150]. The 
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disulfide bonds formed within the ATD are responsible for the modification of 
the Zn2+ binding site[179], so in the present study, we only considered the 
endogenous redox site Cys744 and Cys798 and mutated the cysteine at C744 
residue into alanine. In the study of ethanol inhibition, we found that only the 
dual cysteine mutant G638C/M821C altered ethanol sensitivity, as this mutant 
had decreased ethanol IC50 values, whereas in the group with C744A, GluN1 
(F639C/C744A) exhibited extremely low ethanol sensitivity and the dual 
cysteine mutation F639C/C744A/M821C also significantly decreased ethanol 
sensitivity. When we removed GluN1 (F639C/C744A)/GluN2C from the 
analysis group, a significant difference was obtained in the dual cysteine mutant 
GluN1 (G638C/C744A)/GluN2C (M821C). Although the involvement of Cys744 
altered ethanol sensitivity among the mutants, the trend of change is similar in 
the group with or without C774A. Because the Cys744 is in the LBD, the change 
in this position may alter agonist affinity. In the glutamate concentration-
response experiments, GluN1 (Cys-744)/GluN2C significantly decreased 
steady-state glutamate EC50 values compared to wild type GluN2C-containing 
NMDAR. The cysteine mutants containing C744A all showed decreased 
glutamate EC50 values except the dual cysteine mutant G638C/C744A/M821C. 
Time of decay also showed that mutants containing C744A increased Tau 
values, which is consistent with the increased agonist affinity. Taken together, 
the cysteine mutants containing C744A alter ethanol sensitivity in an additive 
manner. The alcohol molecule acts on the membrane-associated domain 
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instead of the LBD as an antagonist[86, 99, 101-103, 111], so it is likely that the 
mutation at Cys744 causes a long distance effect on the conformational change 
of the MD to affect ethanol sensitivity. We have demonstrated that the change 
in the methionine position in the GluN2A subunit can cause agonist trapping in 
the LBD to alter ethanol sensitivity[110, 111], the change in the LBD may 
subsequently affect the alcohol action in the MD. In this study we used both 
mutant cycle analysis and two-way analysis of variance to test for interactions 
among dual cysteine mutants. Ethanol IC50 values may represent fewer kinetic 
rates compared with steady-state glutamate EC50 values. It has been 
demonstrated that the main action of ethanol on NMDAR kinetics is to decrease 
mean open time[92], whereas glutamate EC50 depends on both agonist 
binding and ion channel gating[114, 182]. Alcohol action in the mutants 
containing C744A may involve multiple kinetic rates, so we only analyzed the 
interaction among the dual cysteine mutants containing Cys744. A significant 
interaction with respect to ethanol sensitivity was obtained in the mutant 
combination G638C/M821C, but not in the mutant F639C/M821C.  
 
The redox site modulation by reducing reagent DTT showed potentiated 
currents in all the dual cysteine mutants. The time constant of decay after DTT 
treatment was significantly increased in dual cysteine mutants containing 
Cys744. Breaking disulfide bonds between two pairs of cysteine residues in the 
GluN1 M3 and GluN2C M4 domain intersubunit interface can regulate receptor 
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kinetics. We showed that mutations at GluN2A (Met-823) can affect agonist 
affinity by trapping the agonist in the closed, desensitized state[110]. Although 
apparent desensitization was not changed by these mutations, these mutations 
are in domains involved in regulating gating and we obtained a significant 
interaction between G638C/M821C with respect to ethanol sensitivity. However, 
we did not detect a significant interaction with respect to deactivation in either 
G638C/M821C or F639C/M821C. The interaction we observed between the 
GluN1 M3 and GluN2C M4 domains cysteine residues may mainly alter the 
local conformational change, which is only reflected in a change in ethanol 
sensitivity.  
 
In summary, taking the results of this study together with those of previous 
studies, we predict an interaction between G638C/M821C involved in 
regulating ethanol action on NMDAR(Figure 18). It will be of interest in future 
studies to test how adjacent amino acid side chains contribute to alter alcohol 









Chapter 6. General Discussion 
We found that the GluN2C (Met-821) is an alcohol sensitive residue, which is 
also responsible for regulating ion channel gating. It is possible that observed 
changes in ethanol sensitivity among the mutants at the methionine position 
result from changes in agonist potency or ion channel gating kinetics. Plotting 
ethanol IC50 values against both peak and steady-state glutamate EC50 values 
revealed there is no correlation. A significant linear relation was obtained when 
ethanol IC50 was plotted versus maximal Iss:Ip values (R2 = 0.501; P < 0.05) 
(Figure 19).  
 
In the study of GluN2A (Met-823), we found that ethanol IC50 was negatively 
correlated with the maximal Iss:Ip values, such that the greater the 
desensitization in a given mutant, the lower its ethanol sensitivity[111]. It is 
possible that GluN2A (Met-823) influences ethanol sensitivity indirectly via 
changes in desensitization. In contrast, we observed a positive linear relation 
between ethanol sensitivity and apparent desensitization among the various 
mutants at GluN2C (Met-821). Ethanol has been shown to influence 
desensitization in several ligand-gated ion channels, including α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA)[183], 5-
hydroxytryptamine (5-HT), and GABA receptors[184]. The opposite effects of 
mutations at GluN2C (Met-821), and its cognate position GluN2A (Met-823) on 
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ethanol sensitivity and desensitization may suggest that ethanol inhibition of 
NMDARs does not involve changes in desensitization.  
Although mutants at GluN2C (Met-821) can alter glutamate EC50 values, we did 
not detect any correlation between ethanol sensitivity and glutamate potency. 
Most mutants showed significantly increased peak glutamate EC50 values, but 
not steady-state glutamate EC50 values. It is possible that the alcohol molecule 
physically interacts with the M821 position and leads to the limited 
conformational changes only in the MD, which will not affect the conformation 
of the LBD. Unlike the trapping theory we observed in GluN2A (Met-823), the 
changes in the GluN2C (Met-821) position only cause short distance changes, 
which only alter the local environment. 
 
Although highly homologous sequences are found among all the GluN2 
subunits, several different amino acids are found in the M4 domain between 
GluN2A and GluN2C subunit (Figure 20). There is only one different residue in 
the M3 domain between GluN2A and GluN2C subunit, and it is located at the 
C-terminal end of the M3 domain. It is unlikely there is either a physical or 
functional interaction between that position and the sites in the M4 domain 
because of the very long distance. We then compared the amino acids near the 
methionine residue between GluN2A and GluN2C subunit. We found that the 
Ala-825 and Ala-826, which are downstream of the GluN2A (Met-823), are Leu-
823 and Val-824 in the GluN2C subunit. Both leucine and valine are 
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hydrophobic amino acids and the side chains are larger than alanine. These 
two amino acids may form a small hydrophobic environment near the 
methionine position, which can significantly alter the alcohol molecule interacts 
with the GluN2C (Met-821) position. We also found another five different amino 
acids located near the C-terminal end of the M4 domain. However, the 
difference in the physical and chemical properties among these amino acids is 
not significant. So, it is unlikely those amino acids can cause long-term effects 
on the alcohol modulation of the GluN2C (Met-821) position.  
 
In the present studies, we showed that the Met-821 position involved in 
regulating ethanol sensitivity and ion channel gating. We also showed Gly-638 
and Met-821 positions in the M3-M4 intersubunit interfaces between GluN1 and 
GluN2C subunits interactively regulate ethanol sensitivity. The results we 
observed from GluN2C-containing NMDAR are different from the previous 
discoveries in the NMDAR containing GluN2A subunit. The difference may 
mainly lies in the sequence difference between GluN2A and GluN2C M4 






























Figure 1. The structural model of M domains of the NMDARs. Shown is 
a model of the NMDA receptor M domains from [1]. M domains of the GluN1 
subunit are shown in yellow, and those of the GluN2A subunit are shown 

























Figure 2. A methionine residue in the M4 domain is highly conserved in 
all GluN subunit.A, shown is the sequences of the M4 domains of the GluN 
subunits. The arrow shows the position of the conserved methionine. B, model 






































Figure 3. Effects of ethanol on tryptophan mutations at the methionine 
residue in the M4 domain of GluN2 subunits. A, concentration-response 
curves for ethanol inhibition of glutamate-activated current in cells 
expressing tryptophan mutations in GluN2 subunits. Data are the means ± 
S.E. of n = 6–9 cells; error bars not visible were smaller than the size of the 
symbols. Curves shown are the best fits to the equation given under 
“Methods” B, graphs plot IC50 values for ethanol in tryptophan mutations in 
GluN2 subunits. Asterisks indicate IC50 values that differed significantly from 















































Figure 4. Single mutations at Met-821 residue in the M4 domain of 
GluN2C subunit can alter ethanol inhibition. A, records are currents 
activated by 300 μM glutamate and 50 μM glycine in the absence and 
presence of 100mM ethanol in cells expressing various mutant GluN2C 
subunit. B, shown are concentration-response curves for ethanol inhibition 
of glutamate-activated current in cells expressing various single site 
substitution mutations in GluN2C. Data are the means ± S.E. of n = 6–9 
cells; error bars not visible were smaller than the size of the symbols. Curves 
shown are the best fits to the equation given under “Methods” C, graphs plot 
IC50 values for ethanol in various single site substitution mutations in 
GluN2C. Asterisks indicate IC50 values that differed significantly from that for 
wild type GluN1/GluN2C subunits (**, p < 0.01 ***, p < 0.001; ANOVA 















































Figure 5. Relation of amino acid physicochemical parameters of the 
substituent at Met-821 to ethanol sensitivity.Graphs plot Log IC50 for 
ethanol versus hydrophilicity (A), molecular volume in Å3 (B), polarity (C), 
and LogP (D). The lines shown are the least-squares fits to the data. No 
significant linear relations were obtained between log IC50 and 















































Figure 6. Triheteromeric GluN1/GluN2A/GluN2C M821G NMDAR Can 
Restore Ion Channel Gating Function. Records are currents activated by 
300 μM glutamate and 50 μM glycine in the absence and presence of 





























































































Figure 7. Single mutations at Met-821 residue in the M4 domain of 
GluN2C subunit can alter the EC50 for peak and steady-state glutamate-
activated current and apparent desensitization. A, records are currents 
activated by 300 μM glutamate in the presence of 50 μM glycine in cells 
expressing various mutant GluN2C subunit. B, concentration-response 
curves for glutamate-activated current in cells expressing various single site 
substitution mutations in GluN2C. Data are the means ± S.E. of n = 6–9 
cells; error bars not visible were smaller than the size of the symbols. Curves 
shown are the best fits to the equation given under “Methods” C, graphs plot 
glutamate EC50 values in various single site substitution mutations in 
GluN2C. D, bar graph shows the average values of maximal steady-state to 
peak current ratio (Iss:Ip) in lifted cells coexpressing GluN1 and WT GluN2C 
subunits or GluN2C subunits containing various mutations at M821. 
Asterisks indicate EC50 values that differed significantly from that for wild 
type GluN1/GluN2C subunits (*, p < 0.05 **, p < 0.01 ***, p < 0.001; ANOVA 















































Figure 8. Relationship between glutamate EC50 and apparent 
desensitization. A, the graph plots values of glutamate log EC50 for steady-
state current versus values of glutamate log EC50 for peak current in the 
series of mutants. Glutamate EC50 values for peak and steady-state current 
were not statistically significantly correlated (R2 = 0.482; P > 0.05). The line 
shown is the least-squares fit to the data. B-C, the graph plots the 
maximal Iss:Ip versus peak (●) and steady-state (○) log EC50 values for 
glutamate-activated current in various GluN2C(Met-821) mutant subunits. 
Maximal Iss:Ip for glutamate was not correlated with steady-state glutamate 
log EC50 (R2 = 0.092; P > 0.05) and peak glutamate log EC50 (R2 = 
0.129; P > 0.05). The lines shown are the least squares fits to the data: peak 















































Figure 9. The deactivation time constant (τ) of substituent at GluN2C 
(Met-821). Bar graph shows the average values of deactivation time course 
in the presence of 300 300 μM glutamate and 50 μM glycine. 
Asterisks indicate Tau that differed significantly from that for wild type 
















































Figure 10. Single tryptophan mutations in the M3 and M4 domains of 
GluN1 and GluN2C subunits can alter ethanol inhibition. A, records are 
currents activated by 300 μM glutamate and 50 μM glycine in the absence 
and presence of 100mM ethanol in cells expressing various mutants. B, 
concentration-response curves for ethanol inhibition of glutamate-activated 
current in cells expressing various single tryptophan substitution mutations. 
Data are the means ± S.E. of n = 6–9 cells; error bars not visible were 
smaller than the size of the symbols. Curves shown are the best fits to the 
equation given under “Methods” C, graphs plot IC50 values for ethanol in 
various single tryptophan substitution mutations. Asterisks indicate 
IC50 values that differed significantly from that for wild type GluN1/GluN2C 















































Figure 11. Cysteine mutations in the M3 and M4 domains of GluN1 and 
GluN2C subunits can alter ethanol inhibition. A, records are currents 
activated by 300 μM glutamate and 50 μM glycine in the absence and 
presence of 100mM ethanol in cells expressing various cysteine mutations. 
B, concentration-response curves for ethanol inhibition of glutamate-
activated current in cells expressing various cysteine mutations. Data are 
the means ± S.E. of n = 6–9 cells; error bars not visible were smaller than 
the size of the symbols. Curves shown are the best fits to the equation given 
under “Methods” C, graphs plot IC50 values for ethanol in various cysteine 
mutations. Asterisks indicate IC50 values that differed significantly from that 
for wild type GluN1/GluN2C subunits (***, p < 0.001; ANOVA followed by 















































Figure 12. Positions in the GluN1 subunit M3 domain interact with 
GluN2C (Met-821) in M4 domain to regulate NMDA receptor ethanol 
sensitivity. A-D, graphs plot ethanol IC50 values versus the substituent at 
position 638 or 639 in GluN1 for mutants at GluN2C position 
821. Asterisks indicate significant interactions detected using log-
transformed IC50 values (**, p < 0.01; ****, p < 0.0001; two-way ANOVA) 
(left panel). Mutant cycle analysis of ethanol IC50 values for the subunit 
combinations. Apparent free energy values associated with the various 
mutations (ΔGX) are given in kcal mol−1. Asterisks indicate a statistically 
significant difference of the apparent interaction energy ΔΔGINT from zero 
















































Figure 13. Cysteine mutations in the M3 and M4 domains of GluN1 and 
GluN2C subunits can alter the EC50 for steady-state glutamate-
activated current. A, records are currents activated by 300 μM glutamate 
in the presence of 50 μM glycine in cells expressing various cysteine 
mutations. B, concentration-response curves for glutamate-activated 
current in cells expressing various cysteine mutations. Data are the means 
± S.E. of n = 6–9 cells; error bars not visible were smaller than the size of 
the symbols. Curves shown are the best fits to the equation given under 
“Methods” C, graphs plot glutamate EC50 values in various cysteine 
mutations. Asterisks indicate EC50 values that differed significantly from that 
for wild type GluN1/GluN2C subunits (**, p < 0.01 ***, p < 0.001; ANOVA 















































Figure 14. The deactivation time constant (τ) of cysteine mutations in 
the M3 and M4 domains of GluN1 and GluN2C subunits. Bar graph 
shows the average values of deactivation time course in the presence of 
300 300 μM glutamate and 50 μM glycine. Asterisks indicate Tau values 
that differed significantly from that for wild type GluN1/GluN2C subunits 















































Figure 15. Positions in the GluN1 subunit M3 domain interact with 
GluN2C (Met-821) in M4 domain to regulate NMDA receptor 
deactivation time course. A-D, graphs plot deactivation time 
constants versus the substituent at position 638 or 639 in GluN1 for 
mutants at GluN2C position 821. Asterisks indicate significant interactions 
(****, p < 0.0001; two-way ANOVA) (left panel). Mutant cycle analysis of 
deactivation time constants for the subunit combinations. Apparent free 
energy values associated with the various mutations (ΔGX) are given in kcal 
mol−1. Asterisks indicate a statistically significant difference of the apparent 
interaction energy ΔΔGINT from zero energy determined using a one-















































Figure 16. Effects of DTT on cysteine mutations in the M3 and M4 
domains of GluN1 and GluN2C subunits. Bar graph summary of the 
percentage of change (mean± SEM) in 300 μM glutamate steady-state (Iss) 
current amplitude after redox modification of wild type and cysteine 
mutations with reducing agent DTT. The percentage of change in Iss after 
DTT treatment is defined as [((Iafter/Iinital) − 1) × 100]. Negative values 
represent a decrease in Iss after DTT reaction, whereas positive values 
represent an increase in Iss. Asterisks indicate the percentage of change that 
differed significantly from that for wild type GluN1/GluN2C subunits (**, p < 















































Figure 17. Effects of DTT on the deactivation time constant (τ) of 
cysteine mutations in the M3 and M4 domains of GluN1 and GluN2C 
subunits. Bar graph shows the average values of deactivation time course 
before and after DTT treatment in the presence of 300 μM glutamate and 50 
μM glycine. Asterisks indicate Tau that differed significantly from that for wild 
type GluN1/GluN2C subunits (**, p < 0.01 ***, p < 0.001; ANOVA followed 















































Figure 18. Model of the MD of the NMDARs. Model of the MDs of the 
GluN1/GluN2C subunit showing M3 and M4 helices (GluN1, yellow; 
GluN2C, green). Other MDs have been removed for clarity. Space-filling 
side groups are shown for the G638C and F639C positions in the M3 helices 
of GluN1, M821C position in the M4 helices of GluN2C. Disulfide bridges 















































Figure 19. Relation of agonist potency, ion channel gating to EtOH 
sensitivity in NMDAR containing GluN2C (Met-821) mutant subunits. A-
C, graph plot log IC50 for EtOH vs log EC50 for glutamate peak and steady-
state current and maximal Iss:Ip. Data points are labeled with the substituted 
amino acid for the various mutants at GluN2C (Met-821). The lines shown 
are the least squares fits to the data. No significant correlations were 
obtained between log EtOH IC50 vs log Ip EC50 (R2 = 0.182; P > 0.05), log Iss 
EC50 (R2 = 0.019; P > 0.05). A significant linear relation was obtained from 















































Figure 20. Model of the MD of the NMDARs. A, model of the MD of the 
GluN2A subunit. Space-filling side groups are shown for the different amino 
acid in the M3 and M4 domains compared to GluN2C subunit. GluN2A (Met-
823) residue is labeled by yellow. B, model of the MD of the GluN2C subunit. 
Space-filling side groups are shown for the different positions in the M3 and 
M4 domains compared to GluN2A subunit. GluN2C (Met-821) is labeled by 
yellow. 
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